Magnetic resonance in medicine · 2026
Real-Time Monitoring of Tissue Oxygenation During Hyperbaric Oxygen Exposure Using In Vivo EPR Oximetry.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kmiec Maciej M, Petryakov Sergey V, Kheirollah Alireza, Ubert Conner S, O'Connell Ryan C, Kuppusamy Periannan
Аннотация
PURPOSE: Hyperbaric oxygen (HBO) therapy increases blood oxygen levels by exposing patients to 100% oxygen under elevated pressure and is used clinically for conditions such as decompression sickness, carbon monoxide poisoning, chronic wounds, and impaired tissue healing. However, real-time precise and quantitative measurement of tissue oxygen tension (pO2) under hyperbaric conditions remains technically very challenging.
METHODS: We developed a specialized small-animal hyperbaric chamber compatible with in vivo electron paramagnetic resonance (EPR) oximetry using customized OxyTrack oxygen detectors. Up to two detectors were implanted simultaneously to measure pO2 in skeletal muscle and tumor tissue in mice. Animals were exposed to air (21% O2) and 100% O2 at both normobaric pressure and 2 atmospheres absolute (ATA) in a stepwise protocol.
RESULTS: The chamber operated safely and stably up to 2 ATA, enabling continuous real-time pO2 monitoring without adverse events and issues with the hardware for up to 90 min. In B16-F10 melanoma, tumor pO2 increased from ∼9 mmHg at baseline to ∼26 mmHg at 100% O2 (1 ATA) and ∼50 mmHg at 2 ATA, with partial retention after decompression. In contrast, SCC7 tumors showed minimal responsiveness (∼9-10 mmHg), whereas skeletal muscle demonstrated marked pressure-dependent increases (up to ∼50 mmHg).
CONCLUSION: The small-animal HBO chamber enables real-time, tissue-specific assessment of oxygen dynamics under clinically relevant hyperbaric conditions. The approach could facilitate optimization of HBO protocols and support translational investigation of oxygen-modulated therapies, including radiation and drug responses in solid tumors.
METHODS: We developed a specialized small-animal hyperbaric chamber compatible with in vivo electron paramagnetic resonance (EPR) oximetry using customized OxyTrack oxygen detectors. Up to two detectors were implanted simultaneously to measure pO2 in skeletal muscle and tumor tissue in mice. Animals were exposed to air (21% O2) and 100% O2 at both normobaric pressure and 2 atmospheres absolute (ATA) in a stepwise protocol.
RESULTS: The chamber operated safely and stably up to 2 ATA, enabling continuous real-time pO2 monitoring without adverse events and issues with the hardware for up to 90 min. In B16-F10 melanoma, tumor pO2 increased from ∼9 mmHg at baseline to ∼26 mmHg at 100% O2 (1 ATA) and ∼50 mmHg at 2 ATA, with partial retention after decompression. In contrast, SCC7 tumors showed minimal responsiveness (∼9-10 mmHg), whereas skeletal muscle demonstrated marked pressure-dependent increases (up to ∼50 mmHg).
CONCLUSION: The small-animal HBO chamber enables real-time, tissue-specific assessment of oxygen dynamics under clinically relevant hyperbaric conditions. The approach could facilitate optimization of HBO protocols and support translational investigation of oxygen-modulated therapies, including radiation and drug responses in solid tumors.